Apolipoprotein E (apoE) receptors, members of the low-density lipoprotein receptor (LDLR) family, contain common structure modules and share sequence homologue. One of the major challenges in the field of apoE receptor biology is to develop receptor-specific reagents including antibodies and cell lines. In the past, unique and specific reagents for apoE/apoE receptors have been developed by the labs of Drs. Bu, LaDu, Rebeck, Estus, and Weeber, and many of these reagents have been validated during the preliminary stage of this program project. The overall goal of the Molecular Cell Biology (MCB) Core is to facilitate studies in this program project by developing, organizing, and distributing apoE/apoE receptor reagents, and to carry out essential assays pertinent to our proposed studies. The five specific aims of the MCB Core are: 1) to develop and store apoE and apoE receptor-specific antibodies, cDNAs, cell lines, and siRNAs;2) to distribute these reagents and protocols to individual labs as they become available or needed;3) to perform standardized assays for apoE, apoE receptors, amyloid p-peptide (Ap), and Ap plaques;4) to make two new transgenic mouse lines and to assist individual projects to study the in vivo role of apoE receptors in these new and existing transgenic and knockout mice;and 5) to collaborate with individual projects to study apoE receptor proteolysis in Alzheimer's disease brains. The specific plans for the MCB Core include a designated technical personnel under the guidance of Dr. Bu to develop, organize, and supervise this Core facility and an easily accessible database documenting the available reagents and the protocols using them. Dr. Bu and the technical personnel will also provide consultations for the end users for technical issues and trouble shooting. These Core services will allow all individual projects to have access to our unique collection of apoE/apoE receptor reagents and to several standardized assays. It is anticipated that each of the five projects will utilize reagents and services from the MCB Core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG030128-05
Application #
8500088
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
5
Fiscal Year
2013
Total Cost
$234,278
Indirect Cost
Name
University of Illinois at Chicago
Department
Type
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Luo, Jia; Lee, Sue H; VandeVrede, Lawren et al. (2016) A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease. Mol Neurodegener 11:35
DiBattista, Amanda M; Dumanis, Sonya B; Newman, Joshua et al. (2016) Identification and modification of amyloid-independent phenotypes of APOE4 mice. Exp Neurol 280:97-105
Cacciottolo, Mafalda; Christensen, Amy; Moser, Alexandra et al. (2016) The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice. Neurobiol Aging 37:47-57
Fu, Yuan; Zhao, Jing; Atagi, Yuka et al. (2016) Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Mol Neurodegener 11:37
Tai, Leon M; Thomas, Riya; Marottoli, Felecia M et al. (2016) The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 131:709-23
Teter, Bruce; LaDu, Mary Jo; Sullivan, Patrick M et al. (2016) Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain. Neuroreport 27:791-5
Yang, Longyu; Liu, Chia-Chen; Zheng, Honghua et al. (2016) LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways. J Neuroinflammation 13:304
Casey, Caroline S; Atagi, Yuka; Yamazaki, Yu et al. (2015) Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway. J Biol Chem 290:14208-17
Zhong, Li; Chen, Xiao-Fen; Zhang, Zhen-Lian et al. (2015) DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response. J Biol Chem 290:15866-77
Liu, De-shan; Pan, Xiao-dong; Zhang, Jing et al. (2015) APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Mol Neurodegener 10:7

Showing the most recent 10 out of 139 publications